Martin Kolev

Company: Apellis Pharmaceuticals

Job title: Associate Director Complement Science

Seminars:

Expanding the Complement Therapeutic Areas: Unlocking the Potential of Gene Therapy & Intracellular Complement 2:30 pm

New opportunities in targeting complement emerge with the discovery of non-canonical roles of complement Recent developments in gene therapy hold promise for the future of complement mediated therapies Technological and knowledge advancements seem poised to expand complement therapies beyond the rare disease spaceRead more

day: Conference Day Two

Panel Discussion: What are the Future Applications of Complement Therapeutics; What Will the Landscape Look Like in 5 Years’ Time? 4:00 pm

Reflecting on all the incredible insights shared today and our key takings, where do we see the complement landscape going? With an increasing appreciation of complement’s role in other conditions, do we see commercial opportunity in tackling neurological diseases? Will emerging modalities and tissue specific therapies reduce safety and toxicity effects of immunosuppressants? With regulatory…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.